Abiopharma

🔍 Sankar Shyam (Executive)

Company: Palantir Technologies Inc. (PLTR)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 35,000 shares of Class A Common Stock (Direct)
  Date: 2026-08-06 | Code: C | equity_swap_involved: 0 | shares_owned_after: 677,786.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,735 shares of Class A Common Stock at $153.4046 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 675,051.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 6,191 shares of Class A Common Stock at $154.653 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 668,860.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 16,063 shares of Class A Common Stock at $155.7404 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 652,797.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 7,976 shares of Class A Common Stock at $156.7791 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 644,821.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,035 shares of Class A Common Stock at $157.4435 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 642,786.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-06 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 599,899.00 | Footnotes: F8
• Sold 35,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-06 | Code: C | equity_swap_involved: 0 | shares_owned_after: 3,628,598.00 | transaction_form_type: 4 | Footnotes: F2, F2, F1, F2, F2

Footnotes:

• F1: This transaction is part of a related series of transactions undertaken on August 6, 2026 pursuant to a preexisting Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on March 11, 2026. The Reporting Person converted 35,000 shares of Class B Common Stock to Class A Common Stock and immediately sold the resulting shares of Class A Common Stock in the open market.
• F2: The Class B Common Stock is convertible into the Issuer's Class A Common Stock on a 1-for-1 basis and has no expiration date.
• F3: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $153.0726 to $153.594. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F4: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $154.1016 to $155.0576. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F5: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $155.2154 to $156.1851. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F6: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $156.2618 to $157.145. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F7: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $157.3622 to $157.5238. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F8: These shares are held of record by Shyam Sankar, Co-Trustee of the Sankar Irrevocable Remainder Trust u/a/d 4/20/2020 (the "Remainder Trust"). These shares were not subject to a particular transaction during the dates covered by this Form 4 and are listed here to disclose the Reporting Person's holdings as required by Securities and Exchange Commission rules. The Reporting Person disclaims beneficial ownership of the shares held by the Remainder Trust, except to the extent of his pecuniary interest therein.
• REMARKS: Officer title: Chief Technology Officer and Executive Vice President. This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person. For additional details regarding the Reporting Person's overall stock and equity holdings, please see the Issuer's Proxy Statement filed with the Securities and Exchange Commission on April 24, 2026, including under the heading "Security Ownership Of Certain Beneficial Owners And Management" (subject to the definitions, explanations, and time periods described therein).